ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,725,014 | +207.8% | 339,735 | +185.4% | 0.01% | +150.0% |
| Q2 2023 | $6,408,193 | +144.1% | 119,045 | +80.1% | 0.00% | +100.0% |
| Q1 2023 | $2,625,174 | -10.0% | 66,092 | -8.8% | 0.00% | 0.0% |
| Q4 2022 | $2,915,750 | +37.7% | 72,477 | +10.0% | 0.00% | 0.0% |
| Q3 2022 | $2,117,000 | -3.9% | 65,874 | -11.3% | 0.00% | 0.0% |
| Q2 2022 | $2,203,000 | +11.5% | 74,230 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $1,975,000 | -38.3% | 70,252 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $3,199,000 | +36.8% | 69,409 | -2.5% | 0.00% | 0.0% |
| Q3 2021 | $2,338,000 | -8.5% | 71,221 | -2.4% | 0.00% | 0.0% |
| Q2 2021 | $2,556,000 | +0.8% | 72,937 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $2,535,000 | +44.1% | 70,143 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $1,759,000 | -16.0% | 60,585 | -18.4% | 0.00% | 0.0% |
| Q3 2020 | $2,094,000 | -15.7% | 74,244 | -3.3% | 0.00% | 0.0% |
| Q2 2020 | $2,485,000 | -77.1% | 76,817 | -71.1% | 0.00% | -80.0% |
| Q1 2020 | $10,841,000 | -51.8% | 266,096 | -27.0% | 0.01% | -28.6% |
| Q4 2019 | $22,472,000 | +52.8% | 364,390 | +80.6% | 0.01% | +75.0% |
| Q3 2019 | $14,709,000 | -16.5% | 201,813 | -5.8% | 0.00% | -20.0% |
| Q2 2019 | $17,611,000 | +149.3% | 214,240 | +113.9% | 0.01% | +150.0% |
| Q1 2019 | $7,065,000 | +37.1% | 100,156 | -12.5% | 0.00% | 0.0% |
| Q4 2018 | $5,153,000 | -47.6% | 114,456 | -34.3% | 0.00% | -33.3% |
| Q3 2018 | $9,843,000 | +22.2% | 174,083 | +44.4% | 0.00% | 0.0% |
| Q2 2018 | $8,054,000 | +232.9% | 120,564 | +190.2% | 0.00% | +200.0% |
| Q1 2018 | $2,419,000 | -87.1% | 41,544 | -85.7% | 0.00% | -85.7% |
| Q4 2017 | $18,752,000 | +1533.4% | 290,950 | +1229.9% | 0.01% | – |
| Q3 2017 | $1,148,000 | +23.4% | 21,878 | +10.1% | 0.00% | – |
| Q2 2017 | $930,000 | -85.5% | 19,878 | -84.6% | 0.00% | -100.0% |
| Q1 2017 | $6,400,000 | -22.4% | 129,263 | -5.0% | 0.00% | -33.3% |
| Q4 2016 | $8,244,000 | -5.8% | 136,001 | +3.2% | 0.00% | 0.0% |
| Q3 2016 | $8,748,000 | -0.3% | 131,843 | -16.1% | 0.00% | 0.0% |
| Q2 2016 | $8,771,000 | +1165.7% | 157,138 | +662.9% | 0.00% | – |
| Q1 2016 | $693,000 | -42.5% | 20,597 | -22.9% | 0.00% | – |
| Q4 2015 | $1,206,000 | +22.2% | 26,730 | +7.0% | 0.00% | – |
| Q3 2015 | $987,000 | -26.7% | 24,977 | +15.1% | 0.00% | -100.0% |
| Q2 2015 | $1,346,000 | -90.7% | 21,698 | -90.7% | 0.00% | -83.3% |
| Q1 2015 | $14,534,000 | +2695.0% | 232,356 | +2423.4% | 0.01% | – |
| Q4 2014 | $520,000 | +261.1% | 9,208 | +81.1% | 0.00% | – |
| Q3 2014 | $144,000 | -14.3% | 5,084 | +4.5% | 0.00% | – |
| Q2 2014 | $168,000 | – | 4,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |